Takeda Pharmaceutical (TAK) Beginning Cash Balance: 2018-2025

  • Takeda Pharmaceutical's Beginning Cash Balance fell 18.29% to $2.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.5 billion, marking a year-over-year decrease of 18.29%. This contributed to the annual value of $2.9 billion for FY2025, which is 24.49% down from last year.
  • As of Q1 2025, Takeda Pharmaceutical's Beginning Cash Balance stood at $2.5 billion, which was down 18.29% from $3.1 billion recorded in Q1 2024.
  • In the past 5 years, Takeda Pharmaceutical's Beginning Cash Balance registered a high of $9.1 billion during Q1 2021, and its lowest value of $2.5 billion during Q1 2025.
  • In the last 3 years, Takeda Pharmaceutical's Beginning Cash Balance had a median value of $3.1 billion in 2024 and averaged $3.2 billion.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Beginning Cash Balance spiked by 55.88% in 2021, and later slumped by 44.83% in 2023.
  • Takeda Pharmaceutical's Beginning Cash Balance (Quarterly) stood at $9.1 billion in 2021, then declined by 19.90% to $7.3 billion in 2022, then crashed by 44.83% to $4.0 billion in 2023, then declined by 23.41% to $3.1 billion in 2024, then fell by 18.29% to $2.5 billion in 2025.
  • Its Beginning Cash Balance was $2.5 billion in Q1 2025, compared to $3.1 billion in Q1 2024 and $4.0 billion in Q1 2023.